Cargando…
Barriers in utilizing lipid-lowering agents in non-institutionalized population in the U.S.: Application of a theoretical framework
Cardiovascular diseases are a major cause of death globally. Epidemiological evidence has linked elevated levels of blood cholesterol with the risk of coronary heart disease. However, lipid-lowering agents, despite their importance for primary prevention, are significantly underused in the United St...
Autores principales: | Alfaifi, Abdullah A., Lai, Leanne, Althemery, Abdullah U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341603/ https://www.ncbi.nlm.nih.gov/pubmed/34352007 http://dx.doi.org/10.1371/journal.pone.0255729 |
Ejemplares similares
-
Sociodemographic characteristics and health-related quality of life of individuals undergoing antidepressant therapy
por: Alfaifi, Abdullah A., et al.
Publicado: (2022) -
A comparison between warfarin and apixaban: A patient's perspective
por: Althemery, Abdullah U., et al.
Publicado: (2020) -
Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008
por: Kuznik, Andreas, et al.
Publicado: (2011) -
Application of the EQ-5D in the Middle East: A Systematic Review Focusing on Patients Living in the Kingdom of Saudi Arabia
por: Althemery, Abdullah
Publicado: (2021) -
Effects of Ultra-Long-Acting Insulin Compared to Long-Acting Insulin on Diabetic Ketoacidosis Incidence in Type 1 Diabetes Mellitus Patients
por: Alsofiani, Wafa A, et al.
Publicado: (2022)